Chronic Administration of Dimebon Ameliorates Pathology in TauP301S Transgenic Mice-Reference-Cited by-同舟云学术

Chronic Administration of Dimebon Ameliorates Pathology in TauP301S Transgenic Mice

Published:2013-01-21 Issue:4 Volume:33 Page:1041-1049
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Peters Owen M.¹,Connor-Robson Natalie¹,Sokolov Vladimir B.²,Aksinenko Alexey Yu.²,Kukharsky Michail S.²³,Bachurin Sergey O.²,Ninkina Natalia¹²³,Buchman Vladimir L.¹

Affiliation:

1. School of Biosciences, Cardiff University, Cardiff, UK

2. Institute of Physiologically Active Compounds of RAS, Chernogolovka, Moscow Region, Russian Federation

3. Institute of General Pathology and Pathophysiology of Russian Academy of Medical Science, Moscow, Russian Federation

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in bioavailability and cognitive-enhancing activity exerted by different crystal polymorphs of latrepirdine (Dimebon®);Frontiers in Pharmacology;2023-02-22

2. Fluorinated γ-carbolines as a promising class of neuroprotective drugs;Russian Chemical Bulletin;2021-05

3. A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice;CNS Neuroscience & Therapeutics;2021-03-23

4. Mitochondria as a promising target for developing novel agents for treating Alzheimer's disease;Medicinal Research Reviews;2020-07-20

5. Fluorinated γ-carbolines as agents for delaying cognitive and motor dysfunctions in a transgenic model of neurodegenerative disorders;Russian Chemical Bulletin;2020-04